Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial)
Objective: Phase I multicenter study defined the maximal tolerated dose (MTD), dose-limiting toxicity (DLT) and safety profile of capecitabine in combination with preoperative radiation for patients with locally advanced rectal cancer (LARC). Material and Method: Patients were treated with oral cape...
Saved in:
Main Authors: | Vutisiri Veerasarn, Pramook Phromratanapongse, Vicharn Lorvidhaya, Prasert Lertsanguansinchai, Chawalit Lertbutsayanukul, Apichart Panichevaluk, Wiroon Boonnuch, Vitoon Chinswangwatanakul, Darin Lohsiriwat, Arun Rojanasakul, Parinya Thavichaigarn, Paiboon Jivapaisarnpong |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33845495420&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/61810 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial)
by: Vutisiri Veerasarn, et al.
Published: (2018) -
Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial)
by: Veerasarn V., et al.
Published: (2014) -
Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m<sup>2</sup>/day
by: Vutisiri Veerasarn, et al.
Published: (2018) -
The surgical outcome of preoperative chemoradiation therapy for ultra low rectal cancer
by: Wiroon Boonnuch, et al.
Published: (2018) -
Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer
by: Vicharn Lorvidhaya, et al.
Published: (2018)